Ramelteon Tablet
Product Images NDC 0591-2191

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ramelteon (NDC 0591-2191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Ramelteon, illustrating its molecular arrangement including a fused bicyclic system with an ether oxygen and an amide side chain.*

FDA Label Image

Image 2

Label for Ramelteon Tablets 8 mg, a film-coated tablet manufactured by Watson Pharma Private Limited for Teva Pharmaceuticals USA, Inc. The label specifies a quantity of 100 tablets and includes storage instructions, prescription-only designation, and a barcode with NDC 0591-2191-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.